CAD-EYE: An Automated System for Multi-Eye Disease Classification Using Feature Fusion with Deep Learning Models and Fluorescence Imaging for Enhanced Interpretability.

Diabetic retinopathy, hypertensive retinopathy, glaucoma, and contrast-related eye diseases are well-recognized conditions resulting from high blood pressure, rising blood glucose, and elevated eye pressure. Later-stage symptoms usually include patches of cotton wool, restricted veins in the optic nerve, and buildup of blood in the optic nerve. Severe consequences include damage of the visual nerve, and retinal artery obstruction, and possible blindness may result from these conditions. An early illness diagnosis is made easier by the use of deep learning models and artificial intelligence (AI). This study introduces a novel methodology called CAD-EYE for classifying diabetic retinopathy, hypertensive retinopathy, glaucoma, and contrast-related eye issues. The proposed system combines the features extracted using two deep learning (DL) models (MobileNet and EfficientNet) using feature fusion to increase the diagnostic system efficiency. The system uses fluorescence imaging for increasing accuracy as an image processing algorithm. The algorithm is added to increase the interpretability and explainability of the CAD-EYE system. This algorithm was not used in such an application in the previous literature to the best of the authors' knowledge. The study utilizes datasets sourced from reputable internet platforms to train the proposed system. The system was trained on 65,871 fundus images from the collected datasets, achieving a 98% classification accuracy. A comparative analysis demonstrates that CAD-EYE surpasses cutting-edge models such as ResNet, GoogLeNet, VGGNet, InceptionV3, and Xception in terms of classification accuracy. A state-of-the-art comparison shows the superior performance of the model against previous work in the literature. These findings support the usefulness of CAD-EYE as a diagnosis tool that can help medical professionals diagnose an eye disease. However, this tool will not be replacing optometrists.